Botox vs. Dysport vs. Xeomin: how the neuromodulator brands compare

If you have decided to try a wrinkle-relaxing injection, you will quickly run into a menu of brand names: Botox, Dysport, Xeomin, and newer arrivals like Jeuveau and Daxxify. They are marketed as if they were meaningfully different products, and patients often assume one must be clearly best. The honest answer is that all of them are forms of botulinum toxin type A, all of them relax the same muscles in the same way, and in skilled hands they produce very similar results. The differences that do exist are real but modest, and they matter more to your injector's technique than to your final look.

They are all botulinum toxin type A

Every product in this category works by the same mechanism covered in neuromodulators: how they soften wrinkles: it temporarily blocks the nerve signal that tells a muscle to contract, so the overlying skin folds less. Botox (onabotulinumtoxinA), Dysport (abobotulinumtoxinA), Xeomin (incobotulinumtoxinA), Jeuveau (prabotulinumtoxinA), and Daxxify (daxibotulinumtoxinA) are all purified forms of the same core molecule. The U.S. Food and Drug Administration has approved each of them for cosmetic use, and the American Academy of Dermatology treats them as one therapeutic class (see the AAD's overview of botulinum toxin therapy). No brand is a different kind of treatment. They are variations on one.

The differences that actually exist

A few genuine differences distinguish the brands, though they are smaller than the marketing suggests. Dosing units are not interchangeable: one unit of Botox is not one unit of Dysport, and injectors convert between them (roughly two to three units of Dysport per unit of Botox), which is why comparing prices by the unit across brands is misleading. Xeomin is a stripped-down formulation that omits the surrounding complexing proteins, which some clinicians believe lowers the odds of the body developing resistance over years of use. Dysport is sometimes described as spreading a little more widely from each injection point, which can be an advantage across a broad forehead and a drawback in a small, precise area. A head-to-head study indexed by the National Library of Medicine found modest differences in how quickly each took effect and how long it lasted (see this randomized comparison of onset and duration), but the gaps were measured in days, not months.

Onset and duration: close, with small edges

In practical terms, most people see Dysport start working a touch faster, sometimes within two to three days rather than the four to five common with Botox, which can matter if you are treating just before an event. Duration is broadly similar across the class, in the three-to-four-month range for most patients, with individual biology mattering more than the brand on the label. Daxxify is the notable exception, marketed for a longer duration, though real-world results have proven more variable than the initial claims. Whichever product you choose, the realistic maintenance rhythm is the same one we lay out in how long Botox and fillers actually last: plan for three to four sessions a year.

Why the injector matters more than the brand

Here is the point the brand debate tends to bury: the single biggest variable in your result is not which toxin was in the syringe, but who held it and how they dosed and placed it. The same product can look natural or frozen depending on the injector's judgment, and a skilled injector produces an excellent result with any of these brands by matching the dose and dilution to your anatomy. This is exactly why choosing a provider for non-surgical facial treatments matters far more than chasing a specific brand name, and why the goal is always a natural, still-expressive result rather than the most product for the lowest price.

Does switching brands make sense?

Some patients switch brands and notice nothing; a few feel one suits them better, whether in onset, how natural it feels, or how long it lasts. Both experiences are normal. A common reason to try a different product is the rare case of apparent resistance after years of treatment, where a protein-free formulation like Xeomin is sometimes suggested. If your current results are good, there is no reason to switch on principle. If they are not, the more productive question is usually about dose, placement, and injector rather than the label. A good provider will happily explain which product they use and why, and will adjust it to you rather than treating the brand as the point.

The takeaway

Botox, Dysport, Xeomin, and the newer neuromodulators are close cousins, not rivals in different weight classes. Their differences in dosing, spread, onset, and duration are real but small, and none of them substitutes for an experienced injector with a natural aesthetic. Choose the person first and let them choose the product. The brand on the vial is one of the least important decisions you will make about your face. The Mayo Clinic's overview of Botox injections is a solid plain-language primer if you want to read more before your consultation.

Related reading: Neuromodulators: how they soften wrinkles.